Unorthodox long-term aerosolized ampicillin use for methicillin-susceptible Staphylococcus aureus lung infection in a cystic fibrosis patient.
Staphylococcus aureus is a significant cause of pulmonary colonization in cystic fibrosis (CF) patients. The optimal strategy of therapy in chronically infected patients with this pathogen is not yet established. We report a successful long-term aerosolized ampicillin treatment of a 14-year-old girl with chronic symptomatic S. aureus lung infection.
Máiz
Luis
L
Cystic Fibrosis Unit, Department of Pulmonology, Hospital Ramón y Cajal, Madrid, Spain. lmaiz.hrc@salud.madrid.org
Lamas
Adelaida
A
Fernández-Olmos
Ana
A
Suárez
Lucrecia
L
Cantón
Rafael
R
D000280:Administration, Inhalation; D000293:Adolescent; D000667:Ampicillin / Q000008:administration & dosage*; D000900:Anti-Bacterial Agents / Q000008:administration & dosage*; D003550:Cystic Fibrosis / Q000382:microbiology*; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D012141:Respiratory Tract Infections / Q000188:drug therapy* / Q000382:microbiology; D013203:Staphylococcal Infections / Q000188:drug therapy*; D013995:Time
D000900:Anti-Bacterial Agents; D000667:Ampicillin